Social Menu

Archive | News

howtargetbotcheditsresponse

Target Continues Facing Backlash From Transgender Bathroom Policy

LifeSiteNews’ call to action over the transgender bathroom policy at one of the nation’s largest retailers continues to have a substantial impact. The April 5 Wall Street Journal (WSJ) cited LifeSite’s #FlushTarget campaign in a report on the negative fallout for Target after announcing its corporate policy allowing  “transgender” bathroom access. “LifeSiteNews put up billboards […]

Continue Reading
wiggens

Deleware: Man Arrested After Fondling Himself In Front Of Women

The Dover Police Department has arrested 56-year-old Marvin Wiggins of Colonia, New Jersey for multiple counts of harassment, lewdness, and disorderly conduct after he approached several women in the Dover area on Thursday and Friday (March 23rd and 24th, 2017).  Wiggins approached women asking for advice on Baby Shower gifts or House warming gifts.  He […]

Continue Reading
rough-sailing

Target Sales into Rough Waters

The NFL doesn’t have to look far to see where this kind of political pigheadedness leads. For the last 10 months, the Target company has taken a beating on Wall Street for racing to embrace the transgender movement. The backlash for opening their fitting rooms and restrooms to anyone has been so severe that executives […]

Continue Reading
target stp

Target Cancels ‘Priority Projects’ In Transgender Policy Backlash

US retail giant Target has scrapped two high priority projects after a public backlash in response to a proposal to introduce transgender-friendly, mixed-sex, bathrooms and fitting rooms. The retailer shut down its ‘Store of the Future’ concept before it kicked off. The project was aimed at promoting a new outlet design combining a smaller upfront […]

Continue Reading
Target-SELL

Goldman Sachs Downgrades Target to Sell

Goldman Sachs downgraded Target (NYSE: TGT) from Neutral to Sell with a price target of $67.00 (from $77.00). Analyst Matthew Fassler comments “We downgrade TGT to Sell from Neutral. Our $67, 12-month price target implies 0% upside vs. 10% average upside for our coverage universe. We expect stagnant to lower earnings to lead to subdued […]

Continue Reading